Lazard Asset Management LLC Sells 2,018,179 Shares of DENTSPLY SIRONA Inc. $XRAY

Lazard Asset Management LLC decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 23.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,715,763 shares of the medical instruments supplier’s stock after selling 2,018,179 shares during the period. Lazard Asset Management LLC’s holdings in DENTSPLY SIRONA were worth $77,903,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its position in DENTSPLY SIRONA by 109.8% in the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after purchasing an additional 6,970,086 shares during the period. Armistice Capital LLC lifted its holdings in shares of DENTSPLY SIRONA by 1,044.0% during the 3rd quarter. Armistice Capital LLC now owns 5,736,000 shares of the medical instruments supplier’s stock valued at $72,790,000 after buying an additional 5,234,587 shares during the period. Jacobs Levy Equity Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 662.0% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 4,608,341 shares of the medical instruments supplier’s stock valued at $58,480,000 after buying an additional 4,003,606 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 827.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock worth $36,378,000 after buying an additional 2,172,343 shares during the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of DENTSPLY SIRONA by 1,032.5% in the 4th quarter. Marshall Wace LLP now owns 2,236,786 shares of the medical instruments supplier’s stock worth $25,566,000 after buying an additional 2,039,280 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Mizuho dropped their target price on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. BMO Capital Markets began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, July 8th. They set a “market perform” rating and a $12.00 price target for the company. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Weiss Ratings downgraded shares of DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Finally, Barclays cut their target price on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a research report on Thursday, June 4th. Three analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $13.42.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $13.02 on Tuesday. DENTSPLY SIRONA Inc. has a 12 month low of $9.40 and a 12 month high of $16.29. The stock has a market cap of $2.61 billion, a price-to-earnings ratio of -4.13, a PEG ratio of 1.54 and a beta of 0.89. The company’s 50 day moving average is $11.14 and its two-hundred day moving average is $11.81. The company has a current ratio of 1.53, a quick ratio of 0.98 and a debt-to-equity ratio of 1.52.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). The firm had revenue of $880.00 million for the quarter, compared to analysts’ expectations of $841.80 million. DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. DENTSPLY SIRONA’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.43 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.42 earnings per share for the current year.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Michael J. Barber purchased 15,175 shares of the business’s stock in a transaction on Thursday, June 11th. The stock was acquired at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the purchase, the director owned 55,943 shares of the company’s stock, valued at approximately $552,716.84. This represents a 37.22% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Brian P. Mckeon purchased 10,000 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were acquired at an average cost of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the acquisition, the director owned 10,000 shares of the company’s stock, valued at approximately $101,200. This trade represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have bought 35,160 shares of company stock worth $351,179. 0.46% of the stock is owned by corporate insiders.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.